Top

Medexus Pharmaceuticals Inc.

TSXV Exchange | Sep 22, 2019, 1:22 PM EDT | Real-time price

MDP $ 4.39 RT
CHANGE
0.06 (1.3857%)
VOLUME
2,950
Day Low: 4.35
Day High: 4.43
Detailed Quote
Open: 4.43
High: 4.43
Beta: 0.3351
Shares Out.: 14,495,660
Total Shares (All Classes)2: 14,610,660
Prev. Close: 4.33
Low: 4.35
VWAP: 4.4117
Market Cap1: 63,635,947
Market Cap (All Classes)2*: 64,140,797
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 14,495,660
EPS: -0.83
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 1.884
Escrow Shares: 0
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action. More

News Headlines for Medexus Pharmaceuticals Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
News Headlines for Medexus Pharmaceuticals Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.